International Flavors & Fragrances Inc.

(New York Stock Exchange)
Back to all articles
Bullish +75

Insiders Pour Millions Into These 2 Stocks — Here’s Why You Might Want to Ride Their Coattails

AI-generated analysis

📈 International Flavors & Fragrances (IFF) is a $19 billion global company developing bioscience-based solutions for flavors, fragrances, and ingredients.

💼 IFF recently divested its Food Ingredients business to CVC Capital Partners for a $4.3 billion valuation, retaining a $200 million minority stake.

📉 The divestiture is expected to generate approximately $3.8 billion in net cash proceeds for debt reduction and share repurchases.

👔 Board member Paul Fribourg purchased 273,500 shares of IFF for $20.3 million shortly after the divestiture announcement.

📊 IFF's first quarter results beat expectations with revenue of $2.74 billion and non-GAAP EPS of $1.25 per share.

🔍 Barclays analyst Lauren Lieberman rates IFF as a Buy with a $90 price target, implying 23% upside potential.

🏆 Wall Street consensus gives IFF a Strong Buy rating based on 11 reviews, with an average price target of $91.78.

🏠 Radian is a mortgage insurance specialist that recently acquired specialty insurer Inigo for $1.67 billion to diversify its business.

📈 Radian's first quarter revenues reached $466 million, representing a 58% increase from the same period in 2025.

💰 CEO-elect Michael Weinbach purchased 170,000 shares of Radian for nearly $5.77 million in early June transactions.

📉 Radian declared a quarterly dividend of 25.5 cents per share, which annualizes to a forward yield of 3%.

🔍 RBC analyst Rowland Mayor rates Radian as Outperform with a $47 price target, suggesting 39% upside potential.

🏆 The Wall Street consensus for Radian is a Moderate Buy based on six recent reviews, with an average price target of $43.50.

Bullish Signals
  • International Flavors & Fragrances (IFF) beat Q1 expectations with revenue of $2.74 billion, which was $99.5 million above estimates.
  • IFF's non-GAAP EPS of $1.25 exceeded analyst expectations by 18 cents per share and showed year-over-year growth.
  • The company generated $92 million in free cash flow for the quarter following the divestiture of its Food Ingredients business.
  • Barclays analyst Lauren Lieberman assigns IFF a Buy rating with a $90 price target, implying a one-year upside potential of 23%.
  • Wall Street consensus rates IFF as a Strong Buy based on 11 reviews, with an average target price of $91.78 suggesting approximately 26% upside from the current trading price of $73.01.
  • Board member Paul Fribourg purchased 273,500 shares for $20.3 million, signaling strong insider confidence in the company's future prospects.
  • Radian Group (RDN) reported total revenues of $466 million in Q1, representing a 58% increase from the first quarter of 2025.
  • Radian's Adjusted diluted net operating income per share rose to $1.27, up 23 cents year-over-year.
  • The company ended the quarter with $55.4 million in unrestricted cash, a significant increase from $16 million a year earlier.
  • CEO-elect Michael Weinbach invested nearly $5.77 million to purchase 170,000 shares, demonstrating strong insider conviction.
  • RBC analyst Rowland Mayor rates RDN as Outperform with a $47 price target, suggesting a potential gain of 39% by next year.
  • Wall Street consensus for Radian is a Moderate Buy based on 6 recent reviews, with an average price target of $43.50 indicating about 29% upside from the current share price of $33.80.
Risk Factors
  • Analyst Lauren Lieberman notes that anticipated dilution from the Food Ingredients sale will weigh on Adjusted EBITDA.
Full Analysis
International Flavors & Fragrances (IFF) is highlighted as a stock with significant insider buying activity, specifically noting that Board member Paul Fribourg purchased 273,500 shares for approximately $20.3 million in late May. This substantial investment follows the company's strategic decision to divest its Food Ingredients business to CVC Capital Partners for a $4.3 billion valuation, a move intended to focus operations on higher-growth segments like Taste, Scent, and Health & Biosciences. The transaction is expected to generate roughly $3.8 billion in net cash proceeds, which management plans to utilize for debt reduction, share repurchases, and reinvestment in core operations. Financially, IFF reported strong first-quarter results with revenue of $2.74 billion, beating analyst expectations by $99.5 million, and non-GAAP EPS of $1.25, which exceeded forecasts by 18 cents per share. The company also generated $92 million in free cash flow for the quarter. Analyst Lauren Lieberman from Barclays maintains a Buy rating with a $90 price target, citing potential multiple expansion and improved free cash flow following the divestiture as key drivers for future performance. Wall Street consensus currently rates IFF as a Strong Buy based on 11 reviews, with an average price target of $91.78 suggesting approximately 26% upside from the current trading price of $73.01.